Seeing Is Believing
Currently out of the existing stock ratings of Michael Okunewitch, 26 are a BUY (96.3%), 1 are a HOLD (3.7%).
Analyst Michael Okunewitch, currently employed at MAXIM GROUP, carries an average stock price target met ratio of 8.04% that have a potential upside of 45.02% achieved within 100 days. Previously, Michael Okunewitch worked at BARCLAYS.
Michael Okunewitch’s has documented 52 price targets and ratings displayed on 8 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on HCWB, HCW Biologics at 28-May-2026.
Analyst best performing recommendations are on ANEB (ANEBULO PHARMACEUTICALS).
The best stock recommendation documented was for ANEB (ANEBULO PHARMACEUTICALS) at 5/15/2025. The price target of $3 was fulfilled within 69 days with a profit of $1.99 (197.03%) receiving and performance score of 28.56.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 01-Sep-2021
$7.5
$0.15 (2.04%)
$10
1 months 29 days ago
(17-Jul-2026)
1/5 (20%)
$0.28 (3.88%)
406
Buy Since 13-Jul-2021
$8
$0.65 (8.84%)
$17
1 months 30 days ago
(16-Jul-2026)
0/8 (0%)
$0.85 (11.89%)
Buy Since 09-Mar-2026
$14
1 months 30 days ago
(16-Jul-2026)
0/2 (0%)
$10.11 (259.90%)
Buy Since 19-Oct-2021
5 months 29 days ago
(17-Mar-2026)
0/8 (0%)
$9.51 (173.22%)
Buy Since 29-Jul-2025
$16
$10.71 (202.46%)
$14
1 years 1 months 14 days ago
(01-Aug-2025)
0/2 (0%)
$11.83 (283.69%)
Which stock is Michael Okunewitch most bullish on?
Which stock is Michael Okunewitch most reserved on?
What Year was the first public recommendation made by Michael Okunewitch?